Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial
Abstract Background The effectiveness of biologic therapies, primarily tumor necrosis factor inhibitors (TNFi), for children with spondyloarthritis (SpA) has made inactive disease a realistic patient outcome. However, biologic therapies are costly, primarily delivered by subcutaneous or intravenous...
Hlavní autoři: | , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
BMC
2023-02-01
|
Edice: | Trials |
Témata: | |
On-line přístup: | https://doi.org/10.1186/s13063-022-07038-6 |